Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Torasemide 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Torasemide (substance) |
Inferred relationship |
Some |
|
Product containing precisely torasemide 100 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Torasemide (substance) |
Inferred relationship |
Some |
|
Torsemide 20mg/2mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Torasemide (substance) |
Inferred relationship |
Some |
|
Torsemide 50mg/5mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Torasemide (substance) |
Inferred relationship |
Some |
|
Torsemide 10mg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Torasemide (substance) |
Inferred relationship |
Some |
|
Product containing torasemide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Torasemide (substance) |
Inferred relationship |
Some |
1 |
Torasemide 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Torasemide (substance) |
Inferred relationship |
Some |
|
Torasemide 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Torasemide (substance) |
Inferred relationship |
Some |
|
Torasemide 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Torasemide (substance) |
Inferred relationship |
Some |
|
Product containing torasemide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Torasemide (substance) |
Inferred relationship |
Some |
1 |
Torasemide-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Torasemide (substance) |
Inferred relationship |
Some |
1 |
Torsemide 10mg/mL injection solution 5mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Torasemide (substance) |
Inferred relationship |
Some |
|
Torsemide 20mg/2mL injection solution 2mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Torasemide (substance) |
Inferred relationship |
Some |
|
Torasemide adverse reaction |
Causative agent (attribute) |
True |
Torasemide (substance) |
Inferred relationship |
Some |
1 |
Allergy to torasemide |
Causative agent (attribute) |
False |
Torasemide (substance) |
Inferred relationship |
Some |
|
Allergy to torasemide |
Causative agent (attribute) |
True |
Torasemide (substance) |
Inferred relationship |
Some |
1 |
Torasemide 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Torasemide (substance) |
Inferred relationship |
Some |
1 |
Torasemide 2.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Torasemide (substance) |
Inferred relationship |
Some |
1 |
Torasemide 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Torasemide (substance) |
Inferred relationship |
Some |
1 |
Torasemide 5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Torasemide (substance) |
Inferred relationship |
Some |
1 |
Torasemide 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Torasemide (substance) |
Inferred relationship |
Some |
1 |
Torasemide 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Torasemide (substance) |
Inferred relationship |
Some |
1 |
Torasemide 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Torasemide (substance) |
Inferred relationship |
Some |
1 |
Torasemide 20 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Torasemide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely torasemide 100 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Torasemide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely torasemide 100 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Torasemide (substance) |
Inferred relationship |
Some |
1 |
Torasemide 2.5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Torasemide (substance) |
Inferred relationship |
Some |
1 |
Torasemide 5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Torasemide (substance) |
Inferred relationship |
Some |
1 |
Torasemide 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Torasemide (substance) |
Inferred relationship |
Some |
1 |
Torasemide 20 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Torasemide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely torasemide 100 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Torasemide (substance) |
Inferred relationship |
Some |
1 |
Torasemide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Torasemide (substance) |
Inferred relationship |
Some |
1 |
Product containing only torasemide in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Torasemide (substance) |
Inferred relationship |
Some |
1 |
Product containing only torasemide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Torasemide (substance) |
Inferred relationship |
Some |
1 |
Spironolactone 50 mg and torasemide 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Torasemide (substance) |
Inferred relationship |
Some |
1 |
Spironolactone 50 mg and torasemide 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Torasemide (substance) |
Inferred relationship |
Some |
1 |
Product containing spironolactone and torasemide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Torasemide (substance) |
Inferred relationship |
Some |
1 |
Product containing only spironolactone and torasemide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Torasemide (substance) |
Inferred relationship |
Some |
1 |
Product containing spironolactone and torasemide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Torasemide (substance) |
Inferred relationship |
Some |
1 |
Product containing only spironolactone and torasemide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Torasemide (substance) |
Inferred relationship |
Some |
1 |
Spironolactone 50 mg and torasemide 20 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Torasemide (substance) |
Inferred relationship |
Some |
1 |
Spironolactone 50 mg and torasemide 20 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Torasemide (substance) |
Inferred relationship |
Some |
1 |